Fluarix-AS25

Fluarix-AS25 appears to reference a specific formulation or variant of the influenza vaccine "Fluarix," but there is no evidence in the provided sources or standard regulatory databases for a product specifically named "Fluarix-AS25." The closest matches are "Fluarix" and its quadrivalent and trivalent formulations, which are inactivated influenza vaccines indicated for active immunization against disease caused by influenza A subtype viruses and type B virus contained in the vaccine. These vaccines work by stimulating an immune response to the hemagglutinin antigens of selected influenza strains, providing protection against seasonal flu. They are developed and manufactured by GSK (GlaxoSmithKline Biologicals) and approved for use in individuals aged 6 months and older[1][3][10]. There is no mention of an adjuvant system labeled AS25 associated with any licensed Fluarix product.

Brand names

Fluarix-AS25Fluarix-AS-25Fluarix-AS 25

Other names

Fluarix-AS25Fluarix-AS-25Fluarix-AS 25